TwinBeech Capital’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
RIM
GCM
CRM
KCM
TwinBeech Capital's LMAT Position: Q4 2022 in Review
TwinBeech Capital sold out of LeMaitre Vascular (LMAT) in Q4 2022, closing a stake of 10,444 shares — an estimated $529K sold.
TwinBeech Capital first reported a position in LMAT in Q4 2021 and held it in 3 quarters. The position peaked at $529K in Q3 2022. 182 funds tracked by Wall St. Rank hold LMAT as of Q4 2022.
- TwinBeech Capital reported no remaining LeMaitre Vascular position as of Q4 2022 after selling out during the quarter.
- TwinBeech Capital sold 10,444 LeMaitre Vascular shares in Q4 2022, an estimated $529K.
- TwinBeech Capital first reported a position in LeMaitre Vascular in Q4 2021 and held it in 3 quarters.
- TwinBeech Capital's LeMaitre Vascular position peaked at $529K in Q3 2022.
- 182 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2022.
Based on TwinBeech Capital's 13F filing for Q4 2022, filed 14 Feb 2023.